Skip to main content
Signal8
Graham Juan profile photo

Juan Graham

CIK: 0001879223

Transaction Breakdown

Open Market Buys (P)1 (16.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)4 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Perspective Therapeutics, Inc. logo
CATX

Perspective Therapeutics, Inc.

Officer
FIBROGEN INC logo
FGEN

FIBROGEN INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Perspective Therapeutics, Inc. logo
    CATX

    Perspective Therapeutics, Inc.

    Mar 28, 2025
    Purchase(P)
    Direct
    33.3K shares at avg. $2.25$75K
  • Perspective Therapeutics, Inc. logo
    CATX

    Perspective Therapeutics, Inc.

    Jan 6, 2025
    Award(A)

    Stock option (right to buy)

    Direct
    400K shares-
  • FIBROGEN INC logo
    FGEN

    FIBROGEN INC

    Dec 7, 2024
    Tax Payment(F)
    Direct
    1.1K shares at avg. $0.34$364.679
  • FIBROGEN INC logo
    FGEN

    FIBROGEN INC

    Dec 6, 2024
    Tax Payment(F)
    Direct
    1.4K shares at avg. $0.34$494.677
  • FIBROGEN INC logo
    FGEN

    FIBROGEN INC

    Sep 7, 2024
    Tax Payment(F)
    Direct
    1.1K shares at avg. $0.39$415.35
  • FIBROGEN INC logo
    FGEN

    FIBROGEN INC

    Sep 6, 2024
    Tax Payment(F)
    Direct
    16.1K shares at avg. $0.39$6K

1-6 of 6

About Graham Juan

Graham Juan (SEC CIK 0001879223) files insider reports with the SEC as Chief Financial Officer of Perspective Therapeutics, Inc. (CATX) and CHIEF FINANCIAL OFFICER of FIBROGEN INC (FGEN).

Signal8 holds 5 ownership filings by Graham Juan (1 Form 3, 4 Form 4), filed between Sep 9, 2024 and Apr 1, 2025. Those filings report 6 transactions, from Sep 6, 2024 to Mar 28, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Graham Juan's filings is in SEATTLE, WA.

Recent filings by Graham Juan

  • Mar 28, 2025: Open-market purchase of CATX shares (Form 4, code P).
  • Jan 6, 2025: Grant or award of CATX derivative securities (Form 4, code A).
  • Dec 7, 2024: Tax withholding of FGEN shares (Form 4, code F).
  • Dec 6, 2024: Tax withholding of FGEN shares (Form 4, code F).
  • Sep 7, 2024: Tax withholding of FGEN shares (Form 4, code F).

Other insiders filing for Perspective Therapeutics, Inc. (CATX)

How to read Form 4 transaction codes